Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure

Detalles Bibliográficos
Autores principales: Cochino, Alexis Virgil, Farkas, Oana Maria, Ioan, Andreea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212399/
https://www.ncbi.nlm.nih.gov/pubmed/35724754
http://dx.doi.org/10.1016/j.jinf.2022.06.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212399/
https://www.ncbi.nlm.nih.gov/pubmed/35724754
http://dx.doi.org/10.1016/j.jinf.2022.06.012

Ejemplares similares